Provided by Tiger Fintech (Singapore) Pte. Ltd.

Nautilus Biotechnolgy, Inc.

0.6884
-0.0246-3.45%
Post-market: 0.68890.0005+0.07%19:48 EDT
Volume:276.30K
Turnover:190.33K
Market Cap:86.84M
PE:-1.22
High:0.7119
Open:0.7044
Low:0.6650
Close:0.7130
Loading ...

We're Keeping An Eye On Nautilus Biotechnology's (NASDAQ:NAUT) Cash Burn Rate

Simply Wall St.
·
31 Mar

Nautilus Biotechnology price target lowered to $2.50 from $4 at Guggenheim

TIPRANKS
·
28 Feb

Nautilus Biotechnology Inc (NAUT) Q4 2024 Earnings Call Highlights: Progress in Proteome ...

GuruFocus.com
·
28 Feb

TD Cowen Reaffirms Their Buy Rating on Nautilus Biotechnolgy (NAUT)

TIPRANKS
·
28 Feb

Nautilus Biotechnology Inc reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
28 Feb

BRIEF-Nautilus Biotechnology Q4 EPS USD -0.14

Reuters
·
27 Feb

Nautilus Biotechnology Q4 Operating Expenses USD 19.98 Million

THOMSON REUTERS
·
27 Feb

Nautilus Biotechnology Inc - Expects Cash Runway Through 2027

THOMSON REUTERS
·
27 Feb

Nautilus Biotechnology Inc - in 2025, We Expect Operating Expenses to Be at or Below 2024 Levels

THOMSON REUTERS
·
27 Feb

Press Release: Nautilus Biotechnology Reports Fourth Quarter and Fiscal Year 2024 Financial Results

Dow Jones
·
27 Feb

Nautilus Biotechnology Q4 GAAP EPS $(0.14) Beats $(0.16) Estimate

Benzinga
·
27 Feb

Nautilus Biotechnology Inc expected to post a loss of 16 cents a share - Earnings Preview

Reuters
·
25 Feb

Blade Air Mobility Leads The Charge Among 3 US Penny Stocks

Simply Wall St.
·
18 Feb

Nautilus Biotechnology to Participate in the TD Cowen 45th Annual Healthcare Conference

GlobeNewswire
·
18 Feb

Nautilus Biotechnology to Announce Fourth Quarter and Full Year 2024 Financial Results on February 27, 2025

GlobeNewswire
·
06 Feb

One Nautilus Biotechnology Insider Raised Their Stake In The Previous Year

Simply Wall St.
·
06 Feb

US Penny Stocks Spotlight: Information Services Group Among 3 Top Picks

Simply Wall St.
·
13 Dec 2024

With 32% ownership, Nautilus Biotechnology, Inc. (NASDAQ:NAUT) insiders have a lot riding on the company's future

Simply Wall St.
·
09 Dec 2024

Nautilus Biotechnology Cut to Sell From Neutral by Goldman Sachs

Dow Jones
·
06 Dec 2024

Goldman Sachs Downgrades Nautilus Biotechnolgy to Sell From Neutral

MT Newswires Live
·
05 Dec 2024